Trial · NCT01999218
Adverse events390
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 390
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Diarrhoea | Gastrointestinal disorders | Ertugliflozin 5 mg | 13 | 445 | 17 |
| other | Diarrhoea | Gastrointestinal disorders | Ertugliflozin 15 mg | 12 | 435 | 12 |
| other | Diarrhoea | Gastrointestinal disorders | Glimepiride | 22 | 435 | 24 |
| other | Common cold | Infections and infestations | Ertugliflozin 5 mg | 21 | 445 | 31 |
| other | Common cold | Infections and infestations | Ertugliflozin 15 mg | 17 | 435 | 29 |
| other | Common cold | Infections and infestations | Glimepiride | 23 | 435 | 31 |
| other | Upper respiratory tract infection | Infections and infestations | Ertugliflozin 5 mg | 27 | 445 | 39 |
| other | Upper respiratory tract infection | Infections and infestations | Ertugliflozin 15 mg | 14 | 435 | 19 |
| other | Upper respiratory tract infection | Infections and infestations | Glimepiride | 18 | 435 | 27 |
| other | Urinary tract infection | Infections and infestations | Ertugliflozin 5 mg | 27 | 445 | 30 |
| other | Urinary tract infection | Infections and infestations | Ertugliflozin 15 mg | 28 | 435 | 33 |
| other | Urinary tract infection | Infections and infestations | Glimepiride | 29 | 435 | 36 |
| other | Asymptomatic hypoglycaemia | Metabolism and nutrition disorders | Ertugliflozin 5 mg | 7 | 445 | 11 |
| other | Asymptomatic hypoglycaemia | Metabolism and nutrition disorders | Ertugliflozin 15 mg | 4 | 435 | 5 |
| other | Asymptomatic hypoglycaemia | Metabolism and nutrition disorders | Glimepiride | 27 | 435 | 87 |
| other | Hypoglycaemia | Metabolism and nutrition disorders | Ertugliflozin 5 mg | 14 | 445 | 31 |
| other | Hypoglycaemia | Metabolism and nutrition disorders | Ertugliflozin 15 mg | 25 | 435 | 53 |
| other | Hypoglycaemia | Metabolism and nutrition disorders | Glimepiride | 82 | 435 | 470 |
| other | Headache | Nervous system disorders | Ertugliflozin 5 mg | 25 | 445 | 27 |
| other | Headache | Nervous system disorders | Ertugliflozin 15 mg | 19 | 435 | 22 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01999218/events